Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Why DexCom Stock Is Falling Today
11:59am, Friday, 29'th Jul 2022
Investors didn't like the company's Q2 update.
DexCom, Inc.'s (DXCM) CEO Kevin Sayer on Q2 2022 Results - Earnings Call Transcript
08:21pm, Thursday, 28'th Jul 2022
DexCom, Inc. (NASDAQ:DXCM ) Q2 2022 Earnings Conference Call July 28, 2022 4:30 PM ET Company Participants Sean Christensen - Investor Relations Kevin Sayer - Chairman, President and CEO Jereme Sylvai
DexCom (DXCM) Matches Q2 Earnings Estimates
06:44pm, Thursday, 28'th Jul 2022
DexCom (DXCM) delivered earnings and revenue surprises of 0% and 0.12%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
DexCom stock drops 17% after company's Q2 miss
05:19pm, Thursday, 28'th Jul 2022
DexCom Inc. DXCM, +1.39% shares fell nearly 17% in the extended session Thursday after the maker of glucose monitoring systems missed analyst expectations for its first quarter and tweaked higher its
Is a Beat Likely for DexCom (DXCM) This Earnings Season?
02:00pm, Tuesday, 26'th Jul 2022
DexCom's (DXCM) second-quarter results are likely to reflect rising global awareness of its real-time CGM.
Better Bear Market Buy: DexCom vs. Intuitive Surgical
06:04am, Saturday, 16'th Jul 2022
Both of these disruptive healthcare companies could be big winners over the long term.
Is DexCom Stock Too Pricey to Buy?
11:30am, Friday, 15'th Jul 2022
Its valuation is expensive, but its future is quite bright.
Investors Wise to Steer Clear of Medtechs Providing Self-Pay Products, Services
06:04pm, Thursday, 14'th Jul 2022
Even after losing nearly 65% of its market value in the first half of the year, Align Technology Inc. ( ALGN , Financial) still does not look like anything approaching a buy. The Phoenix-area company
This Stock-Split Stock Is a Better Buy Than GameStop
10:37am, Thursday, 14'th Jul 2022
DexCom is more of a sure thing in the long run.
Growth stocks remain resilient in weakening economy, says Neuberger's Jason Tauber
05:13pm, Friday, 08'th Jul 2022
Jason Tauber, Neuberger Berman large cap disciplined growth and the disruptors portfolio manager, joins 'Closing Bell: Overtime' to discus his bullish case for the growth trade.
DexCom: Long Term Secular Growth Beneficiary
03:06pm, Friday, 08'th Jul 2022
DexCom has a leading position in a huge and growing market of continuous glucose monitoring. Medical technology is a growing space, with powerful demographic forces leading to outsized long-term growt
Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.
04:04pm, Thursday, 30'th Jun 2022
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2022 financial results after market close on Thursday, July 28, 2022. Management will
With Stock Splits Underway, These 2 Beaten-Down Stocks Are Buys Now
10:23am, Wednesday, 29'th Jun 2022
Don't be too quick to give up on these companies.
3 Stock-Split Stocks You Can Confidently Buy and Hold Forever
05:06am, Tuesday, 28'th Jun 2022
Among the high-profile stocks splitting their shares in 2022, these three offer the most attractive long-term growth prospects.
Here's Why You Should Hold on to DexCom (DXCM) Stock Now
12:27pm, Monday, 20'th Jun 2022
DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.
